Dr. Reddy's unit buys rights to Valeant's skin cream Cloderm

04/3/2011 | MSN

Dr. Reddy's Laboratories subsidiary Promius Pharma agreed to purchase U.S. development and marketing rights to Cloderm, Valeant Pharmaceuticals International's topical drug for skin disorders. Valeant will receive an upfront fee as well as royalties.

View Full Article in:

MSN

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC